期刊文献+

DCF化疗方案在食管胃重复癌症治疗中的临床疗效研究 被引量:1

下载PDF
导出
摘要 目的探讨DCF化疗方案在食管胃重复癌症治疗中的临床效果和安全性。方法按照数字表法将24例食管胃重复癌症患者分为实验组和对照组,每组各12例。实验组患者采用DCF化疗方案进行抗癌治疗,对照组患者应用FOLFOX4化疗方案进行抗癌治疗。治疗2个或3个化疗周期后,比较两组患者的抗癌治疗疗效、生活质量评分及毒副反应发生情况。结果实验组的临床有效率显著高于对照组(P〈0.05),生活质量改善率明显高于对照组(P〈0.05),毒副反应的发生率显著低于对照组(P〈0.05).结论DCF化疗方案治疗食管胃重复癌症的有效率高,可有效改善患者的生活质量,且毒副反应发生率低,安全性高,值得临床推广应用。
出处 《国际医药卫生导报》 2015年第1期72-74,共3页 International Medicine and Health Guidance News
  • 相关文献

参考文献9

  • 1Allum WH, Blazeby JM, Griffin SM, et at.Guidelines for the management of oesophageal and gastric cancer[J].Gut, 2011,60( 11 ): 1449-1472.
  • 2王光军,李朝平,李长青,郭亚雄.同时性食管及食管胃交界区重复癌的外科治疗[J].中国实用医刊,2011,38(12):47-49. 被引量:4
  • 3Trotti A, Byhardt R, Stetz J, el al.Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer lreatmenl: impact on radiotherapy[J].Inl Radiat Oncol Phys, 2000, 47 ( 1 ) : 1347.
  • 4Therasse P. Arbuek SG, Eisenhauer EA, et al. New guidelines to evaluate the response to lrealment in solid tumors. European Organization for Research and Tlatment of Cancer. National Camer Institute of the United Slates, National Caueer Institute of Canada[J].J NatlCancerlnst, 2000, 92 (3) : 205-216.
  • 5Yates JW, Chalmer B, McKegney FP. Evaluation of patients wilh advanced cancer using the Karnoisky pedormance statusJJJ.Cancer, 1980, 45 ( 8 ) : 2220-2224.
  • 6房渝,任冬仁,陈浩,胡建国,陈晓欣.Barrett食管和食管腺癌的动物模型[J].胃肠病学,2012,17(4):193-197. 被引量:6
  • 7Han JS, Choi SR, Jang JS, el al. A case of synchronous esophagus and stomach cancer successfully treated by combined chemotherapy[J]. KoreanJ Gastroenterol, 2012, 60 (2) : ll3-118,.
  • 8顾军,董章霞,王梅.XELOX方案在消化道肿瘤中的应用进展[J].医学研究生学报,2010,23(10):1108-1111. 被引量:13
  • 9季梦遥,谭诗云,张军.小剂量顺铂联合5-氟尿嘧啶对胃癌细胞增殖抑制及其机制的研究[J].现代肿瘤医学,2010,18(5):861-864. 被引量:9

二级参考文献20

  • 1Adolfo Parra-Blanco,María Rosa Arnau,David Nicolás-Pérez,Antonio Z Gimeno-García,Nicolás González,Juan A Díaz-Acosta,Alejandro Jiménez,Enrique Quintero.Endoscopic submucosal dissection training with pig models in a Western country[J].World Journal of Gastroenterology,2010,16(23):2895-2900. 被引量:9
  • 2Sionov RV,Haupt Y.The cellular response to p53:the decision between 1ife and death[J].Oncogene,1999,18:6145-6157.
  • 3Janus F,Albrechtsn N,Dornreiteri,et al.The dua1 role mode1 for p53 in maintaining genomic integrity[J].Cell Life Sci,1999,55:12-27.
  • 4Katerina Chvalova.Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin[J].Nucleic Acid Res,2007,35(6):1812-1821.
  • 5KubotaT.Theoretical basis for low-dose DDP/5-FU therapy[J].Jpn Cancer Chemother,1999,26(11):1536-1541.
  • 6Nishiyama M,Yamamoto W,Park JS,et al.Low-dose cisplatin and 5-fluropyrimidines in combination can express increased gene expression of cellular resistance determinants to themselves[J].Clin Cancer Res,1999,5(9):2620-2628.
  • 7Kim R,Tanabe K,Inoue H,et al.Mechanism of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma[J].Int J Oncol,2002,20(3):549-555.
  • 8Chen X, Li N, Wang S, et al. Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alphadifluoromethylornithine on tumorigenesis in a rat surgical model[J]. Carcinogenesis, 2002, 23 (12): 2095-2102.
  • 9Clark GW, Smyrk TC, Mirvish SS, et al. Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model[J]. Ann Surg Oncol, 1994, 1 (3): 252-261.
  • 10Miyashita T, Ohta T, Fujimura T, et al. Duodenal juice stimulates oesophageal stem ceils to induce Barrett's oesophagus and oesophageal adenocarcinoma in rats [J].Oncol Rep, 2006, 15 (6): 1469-1475.

共引文献28

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部